3/30/21 18:28 | 3/30/21 | HSTO | Health | Drug | Pharmaceutical Preparations | Pascoe Richard W | CA | DO | P,CEO,Di | P | 23 | 1.14 | 0 | 20 | 200 | 30 | D | | | | | | | | | | | | | | |
12/7/20 16:06 | 12/3/20 | HSTO | Health | Drug | Pharmaceutical Preparations | Pascoe Richard W | CA | DO | P,CEO,Di | P | 12 | 1.24 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
5/27/20 06:09 | 5/22/20 | HSTO | Health | Drug | Pharmaceutical Preparations | Marshall Keith W | CA | O | EVP,COO, | M.d | 0 | 0.00 | 0 | 39 | | 20 | D | | | | | | | | | | | | | | |
5/27/20 06:05 | 5/22/20 | HSTO | Health | Drug | Pharmaceutical Preparations | Spada Alfred P. | CA | O | EVP,R,D, | M.d | 0 | 0.00 | 0 | 31 | 242 | 44 | D | | | | | | | | | | | | | | |
5/27/20 06:04 | 5/22/20 | HSTO | Health | Drug | Pharmaceutical Preparations | Mento Steven J | CA | D | | M.d | 0 | 0.00 | 0 | 65 | 376 | 82 | D | | | | | | | | | | | | | | |
5/7/18 19:46 | 5/4/18 | CNAT | Health | Drug | Pharmaceutical Preparations | Mento Steven J | CA | DO | P,CEO,Di | M.d | 59 | 0.9900 | 0 | 60 | 14 | 487 | D | | | | | | | | | | | | | | |
3/1/18 16:08 | 2/27/18 | CNAT | Health | Drug | Pharmaceutical Preparations | Spada Alfred P. | CA | O | EVP,R,D, | M.d | 15 | 1.24 | 0 | 12 | 5 | 259 | D | | | | | | | | | | | | | | |
1/11/17 16:01 | 1/9/17 | CNAT | Health | Drug | Pharmaceutical Preparations | Cashion Charles | CA | O | SVP,Fina | M.d | 42 | 0.9900 | 26 | 42 | 29 | 187 | D | -17 | 163 | 132 | 158 | 176 | 161 | -6 | 0 | 2 | -3 | 2 | 39 | | |
12/22/16 16:04 | 12/20/16 | CNAT | Health | Drug | Pharmaceutical Preparations | Mento Steven J | CA | DO | P,CEO,Di | M.d | 50 | 1.21 | 11 | 41 | 11 | 427 | D | -38 | 45 | 103 | 100 | 159 | 147 | 129 | 126 | 18 | 39 | 18 | 25 | | |
10/31/16 16:37 | 10/27/16 | CNAT | Health | Drug | Pharmaceutical Preparations | Van Wart Harold | CA | D | | M.d | 5 | 0.2500 | 1 | 18 | New | 18 | D | -78 | -56 | -37 | -25 | -2 | -14 | -11 | -15 | -11 | -13 | 5 | 149 | 387 | |
4/10/15 16:02 | 4/8/15 | CNAT | Health | Drug | Pharmaceutical Preparations | Kisner Daniel L | CA | D | | P | 23 | 5.75 | 10 | 4 | 127 | 7 | D | | -18 | -6 | -39 | -6 | -7 | -19 | 0 | 2 | 9 | -6 | -19 | -27 | -48 |
1/10/14 17:07 | 1/8/14 | CNAT | Health | Drug | Pharmaceutical Preparations | Hale David F | CA | D | | M.d | 12 | 0.9900 | 2 | 12 | 8 | 168 | D | | | | 6 | 61 | 56 | 48 | 61 | -16 | -29 | -38 | -68 | -65 | -79 |
9/27/13 16:29 | 9/26/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Hale David F | CA | D | | M.d | 28 | 2.31 | 0 | 12 | New | 12 | D | | | | | 13 | 20 | 11 | 5 | -4 | -1 | -12 | -36 | -20 | -42 |
8/1/13 19:18 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Aberdare Gp Iii, L.L.C. | CA | T | | S.d | -6 | 11.00 | 7 | -1 | 0 | 2,279 | I | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 19:18 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Aberdare Gp Iii, L.L.C. | CA | T | | P.d | 1,182 | 11.00 | 7 | 107 | 5 | 2,279 | I | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 19:18 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Perret Marc Olivier | CA | DT | | S.d | -4 | 11.00 | 7 | 0 | 0 | 1,487 | I | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 19:18 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Perret Marc Olivier | CA | DT | | P.d | 1,821 | 11.00 | 7 | 166 | 13 | 1,487 | I | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 19:16 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Mento Steven J | CA | DO | P,CEO,Di | P.d | 152 | 11.00 | 7 | 14 | 4 | 386 | I | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 19:16 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Klingenstein Paul H | CA | DT | | S.d | -6 | 11.00 | 7 | -1 | 0 | 2,279 | I | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 19:16 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Klingenstein Paul H | CA | DT | | P.d | 1,182 | 11.00 | 7 | 107 | 5 | 2,279 | I | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 19:14 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Malik Shahzad | CA | DT | | S.d | -6 | 11.00 | 7 | -1 | 0 | 4,055 | I | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 19:14 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Malik Shahzad | CA | DT | | P.d | 2,091 | 11.00 | 7 | 190 | 5 | 4,055 | I | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 19:12 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Lacasse Louis P | CA | D | | P.d | 1,363 | 11.00 | 7 | 124 | 18 | 810 | I | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 19:11 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Hale David F | CA | D | | P.d | 28 | 11.00 | 7 | 3 | 2 | 144 | I | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 19:10 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Cooperative Gilde Healthcare II U.A. | P7 | T | | S.d | -4 | 11.00 | 7 | 0 | 0 | 1,487 | D | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 19:10 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Cooperative Gilde Healthcare II U.A. | P7 | T | | P.d | 1,821 | 11.00 | 7 | 166 | 13 | 1,487 | D | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 19:09 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Advent Venture Partners LLP | X0 | T | | S.d | -6 | 11.00 | 7 | -1 | 0 | 4,144 | I | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 19:09 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Advent Venture Partners LLP | X0 | T | | P.d | 2,091 | 11.00 | 7 | 190 | 5 | 4,144 | I | | | | | | | | -5 | -2 | 3 | 0 | 0 | 22 | -13 |
8/1/13 14:21 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Scopa James Paul | CA | D | | P.d | 1,818 | 11.00 | 7 | 165 | 16 | 1,192 | I | | | | | | | | -5 | -1 | 2 | -1 | -1 | 21 | -13 |
8/1/13 14:19 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Evnin Luke | MA | T | | P.d | 1,818 | 11.00 | 7 | 165 | 16 | 1,192 | I | | | | | | | | -5 | -1 | 2 | -1 | -1 | 21 | -13 |
8/1/13 14:18 | 7/30/13 | CNAT | Health | Drug | Pharmaceutical Preparations | Mpm Bioventures IV Qp LP | MA | T | | P.d | 1,818 | 11.00 | 7 | 165 | 16 | 1,192 | I | | | | | | | | -5 | -1 | 2 | -1 | -1 | 21 | -13 |